Probably not that long. Cosmo has been looking at 2015 for the acne treatment and 2016 for the hair loss treatment. With the inevitable timeline creep it's probably 2017 at the earliest, but that's five years away rather than ten.
After Histogen and Replicel, this is the treatment I'm most looking forward to. If it's as effective as the initial trials indicate it should become the new first-line treatment for MPB and consign Propecia to the scrap heap. No systemic effects and only needs to be applied once or twice a week.
The only thing I'm worried about is that they might struggle to attract investors/partners to develop it if the investors are worried Replicel etc will make them obsolete. Which won't happen - even if Replicel is fully effective (and that's a huge IF) there will still be a market for CB-03-01 in prevention of hair loss and maintenance of stuff like Histogen. I'd rather not lose my hair in the first place than need to have Replicel or Histogen at all!
After Histogen and Replicel, this is the treatment I'm most looking forward to. If it's as effective as the initial trials indicate it should become the new first-line treatment for MPB and consign Propecia to the scrap heap. No systemic effects and only needs to be applied once or twice a week.
The only thing I'm worried about is that they might struggle to attract investors/partners to develop it if the investors are worried Replicel etc will make them obsolete. Which won't happen - even if Replicel is fully effective (and that's a huge IF) there will still be a market for CB-03-01 in prevention of hair loss and maintenance of stuff like Histogen. I'd rather not lose my hair in the first place than need to have Replicel or Histogen at all!
Comment